Navigation Links
GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma

patients (8) and a need remains for new treatment options.

"These results clearly demonstrate the potential pazopanib offers as a future therapeutic option not only in renal cell cancer, but across many different tumor types," said Debasish Roychowdhury, MD, Vice President, Global Clinical Development, Oncology Medicine Development Centre, GSK. "The broad clinical development program for pazopanib, in various cancers as monotherapy and in combination therapy, including combinations with Tykerb, underscores our continued commitment to delivering effective new treatments for patients with cancer."

Ovarian cancer study (Abstract 5561) (9)

This ongoing Phase II open-label, monotherapy study is evaluating pazopanib in patients with cancer of the ovary, fallopian tube or peritoneum, who have failed standard platinum-based therapy. Treatment is continued until disease progression, withdrawal due to AEs, or withdrawal of consent. Biological activity (measured as a decrease in CA-125, a biologic marker of clinical activity) was seen in nine (41%) of 22 evaluable patients with relapsed disease. The most common AEs were diarrhea, nausea, abdominal pain, fatigue, and vomiting. Please see safety considerations below.

Globally, ovarian cancer (204,000 cases and 125,000 deaths) is the sixth most common cancer and the seventh most common cause of death from cancer in women. (5) The majority of patients with ovarian cancer will have advanced disease at the time of initial diagnosis. Typically, these patients are managed with surgery followed by combination chemotherapy. Although the majority of patients will respond initially to firstline therapy, recurrent disease remains a considerable problem. (10)

Soft tissue sarcoma study (Abstract 10031) (11)

STS is a disease in which malignant cancer cells begin growing in soft tissues, such as muscles, tendons, connective tissues, fat, blood vessels, nerves, and tissues around joints. This ongoing Ph
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
2. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
3. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
4. MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial
5. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
6. Ceragenix Compound Shows Promise for Treating Lethal Cystic Fibrosis Infections
7. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
8. CombinatoRx Product Candidate CRx-150 Shows Activity on DAS28 and Pain, but Not CRP
9. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
10. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
11. New Poll Shows Men, Women Incorrectly Blame Symptoms of Low Testosterone on Normal Aging
Post Your Comments:
(Date:11/22/2014)... , Nov. 21, 2014  Particle Sciences, Inc ... has developed and manufactured a new innovative vaginal ... Research and Development arm of Exeltis Pharmaceuticals.  According ... Project Management at Particle Sciences, "This vaginal ring ... our material sciences and modeling expertise.  We are ...
(Date:11/21/2014)... Calif. and VIENNA, Va. ... innovative in-home care provider that operates in ... a leading provider of remote caregiving technology. Alta will ... and existing client receiving homecare services. Logo ... this technology is the key to providing the kind ...
(Date:11/21/2014)... 21, 2014  Heated dialogue in recent months about ... cancer treatments to Gilead,s new hepatitis C drug Harvoni® ... world questioning what it means to put a price ... And while drug pricing is one of the ... both a general business and ethical standpoint – it ...
Breaking Medicine Technology:Particle Sciences' Clinical Trial Supplies Group Manufactures Innovative Vaginal Ring 2Alta Home Care, Inc. and BeClose Partner to Enable Seniors to Remain in Their Homes Safely and Securely 2"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 2"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 3"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 4"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 5
... CSL Behring announced today it has been granted national marketing authorization in ... hereditary angioedema (HAE) attacks in any body location. This latest authorization brings the number ... , South America and Australia ) in which Berinert ... In October 2009 ...
... /PRNewswire-FirstCall/ -- Transgenomic, Inc. (OTC Bulletin Board: TBIO) today announced ... presentation regarding the business strategy of the Company at the Noble Financial Sixth ... EDT .  The conference will be held at the Hard Rock Hotel in ... , The presentation ...
Cached Medicine Technology:CSL Behring Announces Completion of National Marketing Authorizations of Berinert® After MRP in 23 European Countries 2CSL Behring Announces Completion of National Marketing Authorizations of Berinert® After MRP in 23 European Countries 3CSL Behring Announces Completion of National Marketing Authorizations of Berinert® After MRP in 23 European Countries 4Transgenomic to Present at the Noble Financial Sixth Annual Equity Conference - ONTRACK 2010 2
(Date:11/23/2014)... NY (PRWEB) November 23, 2014 ... allege heart attacks, strokes, deep vein thrombosis and ... in a federal multidistrict litigation (MDL) underway in ... reports. , Court documents updated on November ... Litigation (JPML) show the filing of 259 lawsuits ...
(Date:11/23/2014)... To show thanks to new and old customers, ... white evening dresses for weddings. Customers who need custom ... is a distinguished dress manufacturer, and it is among the ... for a very long time. The CEO of this company ... be able to buy not only a beautiful dress, but ...
(Date:11/23/2014)... 2014 “BlackVue” was featured on NewsWatch ... which features the latest and coolest technology products available ... for NewsWatch, conducted the product review and shared with ... options in the car camera industry. , The need ... be hard to find the one that’s right per ...
(Date:11/23/2014)... November 23, 2014 Today Zane ... for small businesses, announced their new on demand ... of Employer-Provided Health Insurance. , According ... greatest financial risk facing most American families. It ... small and large, when it comes to recruiting ...
(Date:11/22/2014)... a successful wedding dress shop, has released its new range ... prepare for the wedding season. All of them are offered ... is a reliable company that has many years of history. ... formal wedding guest attire. This new collection comes in many ... As one of the leading companies in the wedding industry, ...
Breaking Medicine News(10 mins):Health News:Testosterone Lawsuits Approach 260 in Illinois Federal Court Litigation, Bernstein Liebhard LLP Reports 2Health News:Testosterone Lawsuits Approach 260 in Illinois Federal Court Litigation, Bernstein Liebhard LLP Reports 3Health News:iFitDress.com: Wonderful White Evening Dresses Now Available 2Health News:A Leader in Front and Rear Facing In-Car Cameras was Featured on NewsWatch Television on October 30, 2014 2Health News:Zane Benefits, Inc. Announces New Webinar on The End of Employer-Provided Health Insurance Now Available On-Demand! 2Health News:Formal Wedding Guest Attire Added to UWDress.com 2
... 21 Florida would likely,suffer significant cuts in ... under the revenue cap proposal the,Taxation and Budget ... to the Washington, DC-based Center on Budget and ... imposes a rigid formula to limit,state and local ...
... A doubling of accidents in 15-year span may reflect ... (HealthDay News) -- Older Americans are being injured during ... new study finds. , The rate of injuries to ... to 2005, said study lead author Dr. Joseph O,Neil, ...
... of Endocrine and Thyroid Surgeons (BAETS, previously the British ... publication of the Second National Endocrine Surgery Audit Report, ... the demographics, investigation, surgery and outcomes of patients with ... the aim of the report to record the current ...
... of LeadCheck(R) Swabs Warns Parents After Survey Finds Contaminated ... ... The makers of LeadCheck(R),Swabs, the leading consumer lead detection kit, today ... scientific survey that found nearly 30 percent of holiday toys,purchased randomly at ...
... 20, 2008)Documenting a twofold to fivefold increase in personal ... at The University of Texas Health Science Center at ... demonstrating the negative impact of chronic insomnia on 11 ... the youths surveyed had one or more symptoms of ...
... use lens is healthy contact lens option for wearers, ... ... JACKSONVILLE, Fla., March 21 For many of the,nation,s 40 ... tearing, and redness caused by contact lens wear, often,hit them ...
Cached Medicine News:Health News:Commission's Revenue Cap Proposal Would Require Cuts in Education, Health, and Safety, and Harm Business Climate 2Health News:More Seniors Falling Victim to Escalator Injuries 2Health News:More Seniors Falling Victim to Escalator Injuries 3Health News:The Second National Audit Report of the BAETS 2Health News:The Second National Audit Report of the BAETS 3Health News:The Second National Audit Report of the BAETS 4Health News:The Second National Audit Report of the BAETS 5Health News:The Second National Audit Report of the BAETS 6Health News:Adolescents with chronic insomnia report 'twofold to fivefold' increase in personal problems 2Health News:Relief "In Sight" for Allergy Sufferers 2Health News:Relief "In Sight" for Allergy Sufferers 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: